Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models

CONCLUSION: This study confirms that EPROI locates resistant tumor hypoxic regions for radiation boost, increasing clonogenic LTCP, with potential enhanced therapeutic index in three tumor types. Preclinical absolute EPROI may provide correction for clinical hypoxia images using additional clinical physiologic MRI.PMID:37904839 | PMC:PMC10613495 | DOI:10.3389/fmed.2023.1269689
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research